Marijuana
Disruptive Behavior
M. H MediCane Ltd.N/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Disruptive Behavior cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
PRAZOSIN Alzheimer's Disease Cooperative Study (ADCS) | Phase 2 | B |
Same molecule, other indications
Marijuana is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →